Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02508246
Title AZD1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Washington
Indications

head and neck squamous cell carcinoma

Therapies

Adavosertib

Docetaxel

Cisplatin

Age Groups: adult
Covered Countries USA


No variant requirements are available.